Fresenius reported EUR1.61B in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Akzo Nobel AKZA:NA EUR 811M 15M
Alcon AG ALC:SW USD 762M 48M
AstraZeneca AZN:LN USD 3.35B 280M
BASF BAS:GR EUR 2.88B 9M
Bayer BAYN:GR EUR 4.08B 393M
Davita Healthcare Partners DVA:US USD 365.45M 50.23M
E.ON EOAN:GR EUR 1.5B 19M
Essilor EI:FP EUR 1.02B 101M
Fresenius FRE:GR EUR 1.61B 21M
Fresenius Medical Care FME:GR EUR 990M 21M
Fresenius Medical Care FMS:US EUR 989.61M 20.12M
Getinge GETIB:SS SEK 1.87B 45M
Givaudan GIVN:VX CHF 530M 34M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
GN Store Nord GN:DC DKK 1.49B 91M
Hikma Pharmaceutical HIK:LN USD 256M 0
Merck MRK:GR EUR 1.55B 26M
Novartis NOVN:VX USD 3.4B 185M
Philips PHIA:NA EUR 1.33B 72M
RWE RWE:GR EUR 961M 327M
Smith & Nephew PLC SN/:LN 1.21B 64M
William Demant Holding WDH:DC DKK 4.9B 265M